[Molecular target therapy for hematologic malignancy].
Mitani
Kinuko
K
D000970:Antineoplastic Agents; D001549:Benzamides; D004791:Enzyme Inhibitors; D018390:Gene Targeting / Q000379:methods; D019337:Hematologic Neoplasms / Q000235:genetics / Q000628:therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000628:therapy; D010879:Piperazines; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines; D014212:Tretinoin
D000970:Antineoplastic Agents; D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D014212:Tretinoin; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases